Pregled bibliografske jedinice broj: 1164729
Optimal treatment of patients with high-risk prostate cancer
Optimal treatment of patients with high-risk prostate cancer // Libri oncologici : Croatian journal of oncology, 46 (2018), 88-94 doi:10.20471/LO.2018.46.02-03.15 (domaća recenzija, pregledni rad, znanstveni)
CROSBI ID: 1164729 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Optimal treatment of patients with high-risk prostate cancer
Autori
Antunac, Katarina
Izvornik
Libri oncologici : Croatian journal of oncology (0300-8142) 46
(2018);
88-94
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
high risk prostate cancer, radiotherapy, hormonal therapy, dose escalation, hypofractionation, simultaneous integrated boost
Sažetak
Treatment options in subset of patients with high-risk prostate cancer are various: radical prostatectomy, hormonal therapy, radiation therapy, combined modality approach, addition of chemotherapy. Based on randomised trials data, optimal approach would consist of radical radiotherapy and long term hormonal therapy. If technically possible high dose radiotherapy, hypofractionation, image guided radiotherapy, simultaneous integrated boost on dominant intraprostatic lesion and HDR brachytherapy boost should be used as well.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
